ADGRE2 and cancer: CD97 is not only induced in tumors, but also undergoes changes in its (sub)cellular location, biochemical structure and/or expression level, resulting in new or altered cellular functions in various malignant tumors, arising from normal CD97-positive cells, such as enterocytes, myocytes, and leukocytes.